Targeting MDA-9 restrains head and neck tumor growth and eliminates therapy resistance
Chemotherapy remains a cornerstone of treatment for head and neck cancers, the seventh-most-common type of cancer worldwide. However, the disease is often diagnosed at a late stage, once it has already spread to other organs, ...
Aug 6, 2026
0
6









